Pharmaceutical

Image

Global Enzyme Replacement Therapy Market – Industry Trends and Forecast to 2028

  • Pharmaceutical
  • Upcoming Report
  • Sep 2021
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Enzyme Replacement Therapy Market, By Enzyme Type (Alglucerase alfa, Imiglucerase, Taliglucerase alfa, Velaglucerase alfa, Others), Indication Type (Gaucher Disease, Fabry Disease, Pompe Disease, Hurler Syndrome, Others), Route of Administration (Oral, Injectable, Others), End Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.

Enzyme Replacement Therapy Market Market Analysis and Insights : Global Enzyme Replacement Therapy Market

The enzyme replacement therapy market is expected to witness market growth at a rate of 6.75% in the forecast period of 2021 to 2028. Data Bridge Market Research report on enzyme replacement therapy market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rapid advancements in the healthcare sector globally is escalating the growth of enzyme replacement therapy market.

Enzyme replacement therapy refers to a medical therapy that is utilized for treating congenital enzyme deficiencies with the use of human and animal or recombinant engineered enzymes. The principle of ERT is defined as a replacement of artificial enzyme in people having enzyme deficiency. Oral and intravenous routes of administration are often used for ERT. Enzyme replacement therapies are generally applied in some lysosomal storage diseases such as Pompe disease, Gaucher disease, and Hurler syndrome among others.

The rise in prevalence of rare diseases across the globe acts as one of the major factors driving the growth of enzyme replacement therapy market. The increase in the demand for ERT to improve the treatment of rare diseases, and surge in government spending on healthcare infrastructure, such as favorable reimbursement for ERT, accelerate the market growth. The increase in adoption of enzyme replacement therapy (ERT) to replace specific defective enzymes in LSD patients with in vitro synthesized functional enzymes, and rise in availability of enzyme replacement therapies, further influence the market. Additionally, focus on importance of patient safety, increase in the population, growth of awareness, improved healthcare infrastructure, and less stringent guidelines for rare diseases positively affects the enzyme replacement therapy market. Furthermore, advancements in the therapy and government support for treatment extend profitable opportunity to the market players in the forecast period of 2021 to 2028.

On the other hand, availability of alternative therapies over enzyme replacement therapies and reimbursement issues in various countries are expected to obstruct the market growth. Lack of skilled professionals and concerns regarding side effects of therapy are projected to challenge the enzyme replacement therapy market in the forecast period of 2021-2028.

This enzyme replacement therapy market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on enzyme replacement therapy market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. 

Global Enzyme Replacement Therapy Market Scope and Market Size

The enzyme replacement therapy market is segmented on the basis of enzyme type, indication type, route of administration, end users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications. 

  • On the basis of enzyme type, the enzyme replacement therapy market is segmented into alglucerase alfa, imiglucerase, taliglucerase alfa, velaglucerase alfa and others.
  • On the basis of indication type, the enzyme replacement therapy market is segmented into gaucher disease, fabry disease, pompe disease, hurler syndrome and others.
  • On the basis of route of administration, the enzyme replacement therapy market is segmented into oral, injectable and others.
  • On the basis of end users, the enzyme replacement therapy market is segmented into hospitals, homecare, specialty clinics and others.
  • On the basis of distribution channel, the enzyme replacement therapy market is segmented into hospital pharmacy, online pharmacy, retail pharmacy and others.

Enzyme Replacement Therapy Market Country Level Analysis

The enzyme replacement therapy market is segmented on the basis of enzyme type, indication type, route of administration, end users and distribution channel.      

The countries covered in the enzyme replacement therapy market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the enzyme replacement therapy market because of the well-developed healthcare infrastructure and the presence of key players within the region. Asia-Pacific is expected to witness significant growth during the forecast period of 2021 to 2028 due to the economically developing and the increase in disposable income in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

The enzyme replacement therapy market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Enzyme Replacement Therapy Market Share Analysis

The enzyme replacement therapy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to enzyme replacement therapy market.

The major players covered in the enzyme replacement therapy market report are CANbridge Life Sciences Ltd., Leadiant Biosciences, Inc., Sanofi, TEIJIN LIMITED, Avid Bioservices, Inc., SmartPharm Therapeutics, GREEN CROSS CORP, Pfizer Inc., GlaxoSmithKline plc., BioMarin, ALLERGAN, Alexion Pharmaceuticals, Inc., Horizon Therapeutics plc, Actelion Pharmaceuticals Ltd, Protalix Biotherapeutics, AbbVie Inc., Johnson & Johnson Services, Inc., Digestive Care, Inc., Takeda Pharmaceutical Company Limited, and Perseo Pharma AG, among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Enzyme Replacement Therapy Market is projected to grow at a CAGR of 6.75% during the forecast period by 2028.
The Enzyme Replacement Therapy Market is segmented on the basis of enzyme type, indication type, route of administration, end users and distribution channel.
The major players in the Enzyme Replacement Therapy Market are CANbridge Life Sciences Ltd., Leadiant Biosciences, Inc., Sanofi, TEIJIN LIMITED, Avid Bioservices, Inc., SmartPharm Therapeutics, GREEN CROSS CORP, Pfizer Inc., etc.
The countries covered in the Enzyme Replacement Therapy Market are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, etc.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials